Athanor Capital, LP - TURNING POINT THERAPEUTICS I ownership

Quarter-by-quarter ownership
Athanor Capital, LP ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q1 2021$226,000
-72.0%
2,394
-63.8%
0.01%
-72.2%
Q4 2020$806,000
+8.3%
6,616
-22.4%
0.02%
-35.7%
Q3 2020$744,000
-18.6%
8,521
-39.8%
0.03%
-39.1%
Q2 2020$914,000
-21.1%
14,146
-23.9%
0.05%
-13.2%
Q4 2019$1,159,000
+29.5%
18,600
-21.8%
0.05%
-8.6%
Q3 2019$895,000
+66.7%
23,800
+80.3%
0.06%
-15.9%
Q2 2019$537,00013,2000.07%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,750,000$260,122,0005.80%
Burrage Capital Management LLC 72,164$6,826,0005.53%
Consonance Capital Management LP 450,396$42,603,0004.54%
MPM BioImpact LLC 269,186$25,462,0003.20%
Orbimed Advisors 2,361,327$223,358,0002.09%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 81,541$7,711,0002.04%
SECTORAL ASSET MANAGEMENT INC 257,879$24,393,0001.85%
Nicholas Investment Partners, LP 218,847$20,701,0001.44%
Logos Global Management LP 140,000$13,243,0001.29%
SILVERARC CAPITAL MANAGEMENT, LLC 16,741$1,584,0000.86%
View complete list of TURNING POINT THERAPEUTICS I shareholders